How can hormones affect women’s heart health?

Hormone changes can be one part of the cardiovascular changes women notice during perimenopause and menopause. During these years, cholesterol, blood pressure, blood sugar, sleep, weight distribution, palpitations, and exercise recovery can change too.

That does not mean hormones caused every change, and menopause does not mean heart disease is inevitable. It means midlife is a useful time to place the pieces beside one another and look again at the whole heart story.

What can change during perimenopause and menopause?

The menopause transition is more than the day periods stop. It is a stretch of years when ovarian hormone patterns change. Research reviewed by the American Heart Association describes this transition as a time when several cardiovascular risk factors may shift.

Cholesterol can rise even when a woman did not suddenly change how she eats. Blood pressure patterns may change. Blood sugar, sleep, body composition, and weight around the middle can change during the same years. Some women also report new pounding, racing, fluttering, or skipped beats.

A 2026 study of 9,248 U.S. women found that, after accounting for age, women classified as perimenopausal had higher odds of falling into the study’s low overall cardiovascular-health group than women who were still having regular periods. Cholesterol and blood sugar showed the clearest differences. The study found an association; it did not prove that hormone changes caused every difference.

This was a cross-sectional analysis comparing different women at one point in time. Menopause stage was based on self-reported menstrual history, only 205 participants were classified as perimenopausal, and the study did not follow women through menopause or measure later heart attacks or strokes.

  • Cholesterol: compare older and newer LDL, HDL, triglyceride, and other lipid results when available.
  • Blood pressure: confirm a possible change with correctly taken readings over time, not one rushed number.
  • Blood sugar: look at the direction of glucose or A1C alongside sleep, medicines, activity, and weight changes.
  • Symptoms: record what a palpitation, breathlessness, or change in exercise tolerance felt like, when it happened, and what came with it.
  • Capacity: notice whether stairs, pace, strength, carrying, and recovery are easier, steady, or becoming harder.

Why hormones should not become the automatic answer

A symptom beginning during perimenopause may still have another explanation. Palpitations can be influenced by sleep, caffeine, alcohol, stress, medicines, thyroid problems, anemia, illness, or a heart-rhythm problem. Higher blood pressure can also relate to family history, kidney health, sleep apnea, pain, medicines, salt, alcohol, and other factors.

The useful question is not only, ‘Could this be hormones?’ It is also, ‘What else could explain it, what pattern do we have, and what question would the right test answer?’ Hormones belong in the story without being asked to explain the whole story.

Your timeline may show more than one isolated result

A lab result is a photograph. A decade of results is a movie. Put older blood-pressure, cholesterol, triglyceride, and blood-sugar results beside the newest ones. Add when periods began changing, when symptoms appeared, and whether medicines, sleep, weight, or activity changed at the same time.

Carry pregnancy history forward too. Preeclampsia, high blood pressure during pregnancy, gestational diabetes, preterm delivery, and having a baby who was small for gestational age can remain useful cardiovascular information years later. These events do not predict one woman’s future by themselves, but they should not disappear from her heart history.

Family history and inherited risk markers may add another layer. The goal is not to collect every possible test. It is to give your clinician enough of the timeline to decide which question deserves first place.

What does hormone therapy mean for the heart?

Menopausal hormone therapy includes systemic products used for symptoms such as hot flashes and night sweats and local vaginal products used for genitourinary symptoms. Their uses, absorption, and risk considerations are not interchangeable.

Hormone therapy is not one drug or one decision. The balance of benefits and risks can differ by the exact hormones, dose, route, timing, duration, whether a woman has a uterus, and her personal history.

In February 2026, the FDA approved revised labeling for a first group of six menopause hormone-therapy products. Several risk statements were removed from boxed warnings. That change did not make every product risk-free, make hormone therapy right for every woman, or turn it into a treatment prescribed simply to prevent heart disease.

A hormone-therapy decision belongs with a qualified clinician who can consider symptoms, age and timing, blood pressure, migraine history, prior venous thromboembolism or inherited clot risk, unexplained vaginal bleeding, estrogen-sensitive cancer history, liver disease, medicines, and cardiovascular history. Internet claims about hormones should not replace that individual review.

What should I bring to a midlife heart conversation?

You do not need a perfect record. Bring what you know, leave what you do not, and organize the facts that may change a decision. A short timeline can be more useful than a pile of disconnected pages.

  • When periods or menopause symptoms began changing.
  • Several recent blood-pressure readings taken with good technique.
  • Older and newer cholesterol, triglyceride, glucose, and A1C results when available.
  • Pregnancy complications and the approximate year they happened.
  • New symptoms, their timing, duration, triggers, and what you felt at the same time.
  • Prescription medicines, over-the-counter products, hormones, and supplements.
  • Any clear change in stairs, pace, strength, recovery, or the activities you want to keep doing.

The HEART RESERVE takeaway

Menopause is not a diagnosis of heart disease and it is not a deadline. It is a checkpoint. Ask what changed, what stayed reassuring, what may have more than one explanation, and which part of the story deserves attention now.

The strongest heart conversation does not separate hormones from blood pressure, cholesterol, glucose, symptoms, pregnancy history, medicines, and physical capacity. It puts them in the same room—without pretending that one fact decides the answer.

Related heart questions

Evidence behind the article

Sources and editorial review

Sources last checked by Lisa for accuracy: September 7, 2026

  1. Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early PreventionAmerican Heart Association · Circulation · 2020
  2. Cardiovascular Health Characterization Using Life’s Essential 8 Score in Perimenopausal WomenJournal of the American Heart Association · 2026
  3. The 2022 Hormone Therapy Position Statement of The North American Menopause SocietyThe North American Menopause Society · Menopause · 2022
  4. FDA Approves Labeling Changes to Menopausal Hormone Therapy ProductsU.S. Food and Drug Administration · 2026
  5. Palpitations across the menopause transition in SWAN: trajectories, characteristics, and associations with subclinical cardiovascular diseaseMenopause · 2023
  6. 2025 Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in AdultsAmerican Heart Association and American College of Cardiology · 2025
  7. Adverse Pregnancy Outcomes and Cardiovascular Disease Risk: Unique Opportunities for Prevention in WomenAmerican Heart Association · Circulation · 2021
  8. Symptoms, Diagnosis and Monitoring of ArrhythmiaAmerican Heart Association · 2024

Independent clinical review is identified only when it has been completed and approved in writing. No external reviewer or organization is implied. Sources do not imply endorsement of HEART RESERVE.